CRIS Current Research Information System

BEDINI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.923
EU - Europa 2.740
AS - Asia 1.287
AF - Africa 376
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.336
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.905
GB - Regno Unito 767
IT - Italia 639
CN - Cina 530
DE - Germania 346
SG - Singapore 304
SE - Svezia 269
VN - Vietnam 195
TG - Togo 163
IN - India 162
UA - Ucraina 140
IE - Irlanda 118
RU - Federazione Russa 106
FR - Francia 94
BG - Bulgaria 84
NG - Nigeria 81
ZA - Sudafrica 68
EE - Estonia 63
CI - Costa d'Avorio 51
JO - Giordania 41
CH - Svizzera 26
HR - Croazia 21
IR - Iran 15
CA - Canada 14
BE - Belgio 11
ES - Italia 11
SC - Seychelles 11
GR - Grecia 9
LB - Libano 8
FI - Finlandia 7
TR - Turchia 7
AT - Austria 6
JP - Giappone 6
NL - Olanda 5
RO - Romania 5
CL - Cile 4
MX - Messico 4
PL - Polonia 4
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
IL - Israele 2
KR - Corea 2
LU - Lussemburgo 2
MA - Marocco 2
PE - Perù 2
TH - Thailandia 2
UZ - Uzbekistan 2
AU - Australia 1
BD - Bangladesh 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EU - Europa 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.336
Salva come PNG Salva come JPEG
Città #
Southend 699
Fairfield 340
Chandler 312
Singapore 256
Ashburn 203
Princeton 185
Bologna 181
Lomé 163
Wilmington 161
Woodbridge 156
Seattle 143
Cambridge 141
Houston 129
Ann Arbor 126
Dublin 117
Dong Ket 102
Jacksonville 86
Sofia 84
Abeokuta 81
Nanjing 81
Westminster 77
Padova 75
Abidjan 51
Medford 50
Beijing 48
Berlin 48
Jinan 48
Saint Petersburg 46
Shenyang 43
Amman 41
Santa Clara 41
Milan 38
Hebei 31
San Diego 30
Nanchang 28
Tianjin 27
Redmond 25
Changsha 22
Mülheim 22
Bremen 20
Norwalk 17
New York 16
Shanghai 16
Falls Church 15
Bern 14
Haikou 14
Des Moines 13
Redwood City 13
Turin 11
Guangzhou 10
Hangzhou 10
Jiaxing 10
Los Angeles 10
Mahé 10
Zhengzhou 10
Brussels 9
Boardman 8
Bühl 8
Frankfurt am Main 8
Ningbo 8
Olalla 8
Taizhou 8
Ardabil 7
Helsinki 7
Istanbul 7
London 7
San Venanzo 7
Wuhan 7
Paris 6
Parma 6
Taiyuan 6
Toronto 6
Cassacco 5
Dearborn 5
Fuzhou 5
Rimini 5
San Francisco 5
Tokyo 5
Bovalino 4
Hyderabad 4
Lanzhou 4
Leawood 4
Manchester 4
Modena 4
Moscow 4
Shenzhen 4
Stillwater 4
Stockholm 4
Verona 4
Ahome 3
Augusta 3
Barcelona 3
Basel 3
Chengdu 3
Chicago 3
Citta 3
Costa Mesa 3
Frankfurt Am Main 3
Gainesville 3
Harbin 3
Totale 4.976
Salva come PNG Salva come JPEG
Nome #
Chitosan-based Polyelectrolyte Complexes for Nasal Drug Delivery 179
Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration 176
A novel family of minimalist opioid peptides deprived of the classic pharmacophores 164
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist 161
Ligand Based Approach to L-Type Calcium Channel by Imidazo[2,1-b]thiazole-1,4-Dihydropyridines: from Heart Activity to Brain Affinity 154
Transcription factor REST negatively influences the protein kinase C-dependent up-regulation of human mu-opioid receptor gene transcription 147
REST is up-regulated by epidermal growth factor in HeLa cells and inhibits apoptosis by influencing histone H3 acetylation 147
T cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional {micro}-opioid receptors. 146
Diphenidol-related diamines as novel muscarinic M4 receptor antagonists 145
Nociceptin/orphanin FQ antagonizes lipopolysaccharide-stimulated proliferation, migration and inflammatory signaling in human glioblastoma U87 cells 138
Ac-D-Trp-PheNH2 AND Ac-D-Trp-Phe-GlyNH2 - A NEW CLASS OF UNUSUAL OPIOID PEPTIDES 137
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs 137
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics 135
A Blocking Group Scan Using a Spherical Organometallic Complex Identifies an Unprecedented Binding Mode with Potent Activity In Vitro and In Vivo for the Opioid Peptide Dermorphin 134
Therapeutic Targeting of Eosinophil Adhesion and Accumulation in Allergic Conjunctivitis 129
DESIGN AND SYNTHESIS OF OPIOID PEPTIDE ANALOGUES AND MIMETICS 125
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 125
Mu opioid receptor stimulation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms 122
Plasma nociceptin/orphanin FQ levels in response to the hyperventilation test in healthy subjects. 120
Opioid Activity Profiles of Oversimplified Peptides Lacking in the Protonable N-Terminus 118
Imidazo[2,1-b]thiazole System: a Scaffold Endowing Dihydropyridines With Selective Cardiodepressant Activity 116
A new generation of opioid peptidomimetics acting as central and/or peripheral analgesics 116
Bioluminescence resonance energy transfer (BRET) to detect the interactions between kappa opioid receptor and non visual arrestins. 115
Role of nociceptin/orphanin FQ in thermoregulation 112
The Inverse Type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists. 111
Plasma nociceptin/orphanin FQ levels rise after spontaneous episodes of angina, but not during induced myocardial ischemia 111
Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastine 111
Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes 109
Prodynorphin-derived peptides 108
Investigation of the Interaction Between the Atypical Agonist c[YpwFG] and MOR 104
Transcriptional activation of human mu-opioid receptor gene by insulin-like growth factor-I in neuronal cells is modulated by the transcription factor REST 103
Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis 100
Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist 99
Versatile Picklocks to Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe- d -Pro-Phe-Trp] (CJ-15,208) 95
null 93
DETERMINATION OF THE BIOLOGICALLY ACTIVE STRUCTURE OF THE ATYPICAL MOR-LIGAND c[D-Asp-1-amide-beta-Ala-D-Trp-Phe] AND ANALOGUES BY NMR AND MOLECULAR DOCKING 90
Renilla luciferase reporter assay to study 3'UTR-driven posttranscriptional regulations of OPRM1. 90
Interactions between atypical opioid agonists and MOR 86
Inhibition of Toll-like Receptor 4 (TLR4)-induced NF-kB activation by NOP is lost in human glioblastoma cells chronically exposed to LPS. 85
mu-opioid receptor (MOR) expression and opioid-mediated intracellular signalling are altered in glial cells exposed to TNF-alpha 84
Biphasic modulation of mu-opoid receptor (MOR) transcription by nociceptin in neuroblastoma cells co-expressing MOR and NOP receptors 82
Molecular Mechanisms Mediating Nociceptin/Orphanin FQ Receptor Signaling, Desensitization and Internalization. 82
Development and characterization of Endomorphin-1 analogues as novel potential analgesic drugs. 80
Development and characterization of novel EphB1 receptor antagonists. 80
Investigation on MOR receptor activation by atypical mechanisms 79
Innovative opioid peptides and biased agonism: Novel avenues for more effective and safer analgesics to treat chronic pain 79
Synthesis of tripeptides containing D-Trp substituted at indole ring, and assessment of MOR affinity and in vivo central antinociception. 78
Identification of a new, functional cross-talk between EphB1 receptor and mu opioid receptor 78
Development and characterization of novel EphB1 receptor antagonists. 77
Expression of the transcription factor REST at different stages of neuronal differentiation: contribution of PKC and WNT/-catenin signaling 76
PKC regulates MOR transcriptional activity: role of the proximal region of the promoter 72
At the cross-roads between immune system and nervous system: expression and intracellular signalling of opioid and opioid-related receptors in human glial cells exposed to pro-inflammatory stimuli. 71
Development and characterization of novel EphB1 receptor antagonists 69
Reactive oxygen species (ROS) generation is stimulated by opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation 68
Genomic and non-genomic effects of anabolic steroids on opioid receptor gene expression in neuronal cells 66
Identification of a novel, functional cross-talk between EphB1 receptor and mu opioid receptor. 66
Bioluminescence resonance energy transfer (bret) to detect the interactions between kappa opioid receptor and nonvisual arrestins 65
Insulin-like Growth Factor I (IGF-I) induces human mu opioid receptor (MOR) expression in differentiated neurons: role of transcription factors REST and STAT3 64
PKC modulation of mu-opioid receptor gene (OPRM1) transcription is influenced by the transcription factor REST 64
The ocular antiallergic action of mapracorat, a novel selective glucocorticoid receptor agonist, involves eosinophils and mast cells: evidence from human cells in vitro and an animal model 62
Novel Antagonist targeting EphB1 receptor 60
Protein Kinase C-dependent up-regulation of human mu-opioid receptor gene (OPRM1) transcription is negatively influenced by the transcription factor REST 59
Identification of a novel, functional cross-talk between EphB1 receptor and mu opioid receptor 58
Opioid activity profiles of peptides containing overlapping portions of CJ-15,208 and CycloEM, and identification of the bioactive conformations 57
Neuron-Glia cross-talk: pharmacological and biotechnological strategies to identify novel therapeutic targets for neuropatic pain 56
Insulin-like Growth Factor I (IGF-I) modulates hMOR transcription in neuronal cells: role of STAT3 56
Pro-inflammatory stimuli increase mu-opioid receptor (MOR) number on cell surface of human glioblastoma cells but hamper opioid agonist-induced intracellular signaling. G-protein-coupled-receptors: from structural insights to functional mechanisms 56
Ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist, involves eosinophil's apoptosis. 56
null 54
Novel Antagonist targeting EphB1 receptor 54
TRYptophan-COntaining Non-Cationizable Opioid PeptideS (TRYCONCOPS): A new paradigm for opioid peptides 54
Regulation of mu-opioid receptor by gene transcription 53
Expression of the Cannabinoid Receptor type I in T-cells and its regulation by cannabinoids and IL-4 53
Endomorphin-1 analogues as novel and highly selective MOPr agonists: design and characterization of innovative analgesic drugs 52
TNF-alpha-induced MOR up-regulation in human glioblastoma cells is coupled to a loss of MOR-activated signalling to intracellular effectors 50
Mechanisms of morphine-induced suppression of T-cell signaling. 47
Functional cross-talk between TLR4 and NOPr in human glial cells. 47
Renilla luciferase reporter assay to study 3′-utr-driven posttranscriptional regulation of oprm1 47
Trypoids, a novel group of mu-opioid receptor-selective di- and tri-peptides: design and characterization of novel analgesics 46
Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics 42
Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model 40
Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late phase experimental ocular allergy 33
The quest for more effective analgesics with reduced abuse liability and fewer adverse effects: Promises, pitfalls, and future perspectives of biased agonists at opioid receptors 27
Totale 7.492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.191 0 0 0 102 121 130 166 190 226 110 36 110
2020/2021965 197 90 35 60 20 41 42 57 70 46 64 243
2021/20221.472 164 80 66 61 147 73 64 144 63 88 213 309
2022/20231.667 177 310 75 184 148 128 81 85 282 40 96 61
2023/2024513 37 74 23 35 34 133 40 29 28 23 35 22
2024/2025592 57 294 190 51 0 0 0 0 0 0 0 0
Totale 7.492